New Product Development
Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow are damaged. This damage leads to low numbers of one or more type of blood cells. MDS is considered as a type of cancer. Myelodysplastic syndromes are a rare group of disorders in which body no longer makes enough healthy …
Continue reading “Myelodysplastic Syndrome Treatment Market to reach US$ 5,614.1 million by 2032”
This Precision Cancer Imaging market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the …
[305 Pages Report] Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Canine Flu Therapeutics Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast. The team …
As per Future Market Insights’ latest analysis, the global hemostatic gels market is estimated to reach a valuation of US$ 1 Bn in 2022, with sales projected to grow at a 6.8% CAGR over the forecast period. Against this backdrop, the market size will surpass US$ 1.9 Bn by 2032. Increasing adoption of hemostatic gels during surgical procedures for blood loss management is spurring demand …
[324 Pages Report] During the forecast period, the paediatric spasticity treatment market is expected to grow at a CAGR of 10%. Rising demand for combination products such as benzodiazepines, imidazole, and gamma-aminobutyric acid analogues is driving the global paediatric spasticity treatment market. Furthermore, demand for paediatric spasticity treatment is increasing as a result of increased awareness and …
As per Future Market Insights’ latest industry analysis, the valuation for the global menopause treatment market in 2022 is estimated to be around US$ 13.3 Bn in 2022 and is projected to exhibit growth at a CAGR close to 5.5% over the forecast period, to reach an estimated valuation of US$ 22.9 Bn in 2032. Hormone therapy comes with side effects due to …
The orthobiologics market is expected to grow at a 3.5% CAGR to reach US$ 6.5 billion by 2027. Furthermore, developments taking place in the market, various trends impacting the performance of the market and other drivers fuelling revenue growth of the global orthobiologics market are enumerated in this elaborate research study. Certain challenges that are pulling market …
The global keloid treatment market was worth US$ 3.6 billion in 2021 and is predicted to be worth US$ 3.7 billion by the end of 2022. Furthermore, with the global frequency of keloid increasing, the overall demand for keloid therapy is expected to expand at a 3.2% CAGR between 2022 and 2032, totaling US$ 5.1 …
According to Future Market Insights, a new study has forecast the DNA polymerase market to exhibit a CAGR of approximately 6.5% during the forecast period. A growing number of drug patent expirations and the interest in generic biologics has gained significantly from developments in the DNA polymerase market. Rising demand for improvements in healthcare diagnostics are …
The global spinal fusion market is estimated to grow at a 5.5% CAGR from 2022 to 2032, with a valuation of US$ 9.49 billion by the end of 2022 and a valuation of US$ 16.2 billion by the end of 2032. According to a recent study, the market value for spinal fusion is approximately 72.5% …